Navigation Links
Blood Clotting Protein Discovered

The protein which is capable of controlling the clotting of blood by preventing blood platelets sticking together has been discovered by a research team belonging to the University of North Carolina. Several deaths are caused by interactions between blood platelets when strokes and heart// attacks take place, which are altogether uncontrolled.

The GPIIb/IIIa is kept in an inactive state by the CIB1. The interactions between platelets in the blood are also prevented because of this. The CIB1 thus plays the role of a gatekeeper with regard to GPIIb/IIIa activation. The CIB1 protein was discovered in 1997 inside platelets which binds to GPIIb/IIIa.

The GPIIb/IIIa which is normally inactive becomes activated during the course of clotting. New therapeutic approaches may result from the knowledge with regard to the functions of the CIB1. The GPIIb/IIIa was seen to become more responsive with the decrease of CIB1 in the cells, while GPIIb/IIIa activation is prevented with the higher amounts of CIB1.

A platelet remains inactive so long as the GPIIb/IIIa and the CIB1 are bound together. While the adhesion receptor is bound to the CIB1, the talin is prevented from activating and binding the receptor. Further studies are planned with regard to the mechanisms of interaction between the CIB1/GPIIb/IIIa, which will lead to better therapies being developed.
'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 , ... ... decreases in medical payments per workers’ compensation claim in 2013 and 2014, according to ... Workers Compensation Research Institute (WCRI) . , According to the study, medical payments per ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance Agency, ... Hamilton County, is embarking on a charity drive with the aim of generating ... for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts volunteers ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a locally owned ... clients in the northern Alabama and Georgia regions, is embarking on a charity ... Works has built a network of support and education facilities to develop and ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... Atlanta, Georgia (PRWEB) , ... ... ... announced today it has acquired Presence Technology, S.L. (“Presence”) for a purchase ... certain price adjustments and other considerations. Presence’s annual revenue is approximately $13.2 ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
(Date:12/8/2016)... -- A new study by a pair of Geisinger Health ... to treat chronic pain is not only ineffective, it ... including death. Palliative care physicians Mellar ... M.D., authored the study which provides a review of ... was published in the December 2016 edition of Current ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
Breaking Medicine Technology: